ENTPD2 and nonpapillary renal cell carcinoma: These findings confirm the dysregulation of IMRGs in ccRCC, consistent with their roles (apart from DBH, CCR4, CMA1 and ENTPD2) in tumor progression and their inclusion in the prognostic model.